206 related articles for article (PubMed ID: 16714226)
1. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
2. Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.
Todd DA; Gulledge TV; Britton ER; Oberhofer M; Leyte-Lugo M; Moody AN; Shymanovich T; Grubbs LF; Juzumaite M; Graf TN; Oberlies NH; Faeth SH; Laster SM; Cech NB
PLoS One; 2015; 10(5):e0124276. PubMed ID: 25933416
[TBL] [Abstract][Full Text] [Related]
3. Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.
Cech NB; Tutor K; Doty BA; Spelman K; Sasagawa M; Raner GM; Wenner CA
Planta Med; 2006 Dec; 72(15):1372-7. PubMed ID: 17054047
[TBL] [Abstract][Full Text] [Related]
4. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
5. Echinacea alkylamides modulate induced immune responses in T-cells.
Matthias A; Banbury L; Bone KM; Leach DN; Lehmann RP
Fitoterapia; 2008 Jan; 79(1):53-8. PubMed ID: 17855021
[TBL] [Abstract][Full Text] [Related]
6. Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats.
Ramasahayam S; Baraka HN; Abdel Bar FM; Abuasal BS; Widrlechner MP; Sayed KA; Meyer SA
Planta Med; 2011 Nov; 77(17):1883-9. PubMed ID: 21870322
[TBL] [Abstract][Full Text] [Related]
7. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
[TBL] [Abstract][Full Text] [Related]
8. Analysis of alkylamides in Echinacea plant materials and dietary supplements by ultrafast liquid chromatography with diode array and mass spectrometric detection.
Mudge E; Lopes-Lutz D; Brown P; Schieber A
J Agric Food Chem; 2011 Aug; 59(15):8086-94. PubMed ID: 21702479
[TBL] [Abstract][Full Text] [Related]
9. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS.
Spelman K; Wetschler MH; Cech NB
J Pharm Biomed Anal; 2009 Jul; 49(5):1141-9. PubMed ID: 19321283
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins.
Dalby-Brown L; Barsett H; Landbo AK; Meyer AS; Mølgaard P
J Agric Food Chem; 2005 Nov; 53(24):9413-23. PubMed ID: 16302756
[TBL] [Abstract][Full Text] [Related]
11. Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.
Fonseca FN; Papanicolaou G; Lin H; Lau CB; Kennelly EJ; Cassileth BR; Cunningham-Rundles S
Int Immunopharmacol; 2014 Mar; 19(1):94-102. PubMed ID: 24434371
[TBL] [Abstract][Full Text] [Related]
12. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats.
Goel V; Chang C; Slama JV; Barton R; Bauer R; Gahler R; Basu TK
Int Immunopharmacol; 2002 Feb; 2(2-3):381-7. PubMed ID: 11811940
[TBL] [Abstract][Full Text] [Related]
13. High performance liquid chromatography/electrospray ionization mass spectrometry for simultaneous analysis of alkamides and caffeic acid derivatives from Echinacea purpurea extracts.
Cech NB; Eleazer MS; Shoffner LT; Crosswhite MR; Davis AC; Mortenson AM
J Chromatogr A; 2006 Jan; 1103(2):219-28. PubMed ID: 16298376
[TBL] [Abstract][Full Text] [Related]
14. Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model.
Matthias A; Blanchfield JT; Penman KG; Toth I; Lang CS; De Voss JJ; Lehmann RP
J Clin Pharm Ther; 2004 Feb; 29(1):7-13. PubMed ID: 14748892
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis.
Tsai YL; Chiu CC; Yi-Fu Chen J; Chan KC; Lin SD
J Ethnopharmacol; 2012 Oct; 143(3):914-9. PubMed ID: 22971663
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of innate and adaptive immune functions by multiple Echinacea species.
Zhai Z; Liu Y; Wu L; Senchina DS; Wurtele ES; Murphy PA; Kohut ML; Cunnick JE
J Med Food; 2007 Sep; 10(3):423-34. PubMed ID: 17887935
[TBL] [Abstract][Full Text] [Related]
19. Effect of drying temperature on alkylamide and cichoric acid concentrations of Echinacea purpurea.
Stuart DL; Wills RB
J Agric Food Chem; 2003 Mar; 51(6):1608-10. PubMed ID: 12617592
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes.
Matthias A; Gillam EM; Penman KG; Matovic NJ; Bone KM; De Voss JJ; Lehmann RP
Chem Biol Interact; 2005 Jun; 155(1-2):62-70. PubMed ID: 15885678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
